Study of the Fecal Microbiome in Patients With Parkinson's Disease
Status:
Active, not recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the intestinal microbiome in subjects with
Parkinson's disease and to determine safety and trends in improvements in diversity of
colonic microbiome following administration of lyophilized PRIM-DJ2727
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborators:
Kelsey Research Foundation Kelsey Seybold Research Fundation